Venture startup

Who invested in Nightingale Health

One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

Undisclosedraised across 1 round since 2020, from 1 source

Latest round
VentureJan 2020
Investors
3
See who backed them

The rounds

  1. Jan 2020
    VentureAmount undisclosed

    Source recorded

Founders and team

From Nightingale Health's own website: 2 founders, 3 on the team.

Teemu SunaChief Executive Officer, Founder
Antti KangasChief Technology Officer, Founder
  • Janna RantaChief Operating Officer
  • Minja SalmioChief Commercial Officer, EMEA
  • Satu SaksmanChief Commercial Officer, APAC

Everyone who backed them

European Investment BankGovernment1round
Business FinlandAccelerator1round
StartUp HealthVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Nightingale Health as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

Cor GroupVC firmPer its own site

Quick answers about Nightingale Health

Who invested in Nightingale Health?

Nightingale Health's investors include European Investment Bank, Business Finland and StartUp Health.

How much has Nightingale Health raised?

Nightingale Health has raised 1 round since 2020, none with a disclosed amount.

When did Nightingale Health last raise?

Nightingale Health's most recent round was a Venture in Jan 2020.

Who backed Nightingale Health first?

Nightingale Health's first round on record, in Jan 2020, was backed by European Investment Bank, Business Finland and StartUp Health.

What stage is Nightingale Health at?

Nightingale Health's latest named round is a Venture, in Jan 2020.

Companies like Nightingale Health

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.